Actively Recruiting

Phase Not Applicable
Age: 30Years - 55Years
FEMALE
ID07130318

Mediterranean Diet in Familial Mediterranean Fever: Is Fatty Liver Affected by Addition of Elliptical Aerobic Exercise

Led by Cairo University · Updated on 2025-08-19

40

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research investigates how aerobic exercise added to a Mediterranean diet affects non-alcoholic fatty liver disease in women with Familial Mediterranean Fever (FMF). FMF is a condition that can impact liver function, and current treatments mainly focus on exercise and diet limitations. The study aims to understand whether exercise can improve liver health alongside traditional drug therapy with colchicine. Participants will be divided randomly into two groups, each with 20 women diagnosed with FMF and fatty liver. Both groups will continue their daily colchicine treatment and follow a Mediterranean diet for six months. One group will also perform elliptical aerobic exercise for 40 minutes, three times a week, throughout the same six-month period. During the study, researchers will measure liver enzymes like aspartate transaminase after six months to assess liver function. Other measurements include body mass index, waist circumference, cholesterol levels, and inflammation markers. The study will monitor participants' health and responses to the diet and exercise over the full six-month period.

CONDITIONS

Brief Title

Mediterranean Diet in Familial Mediterranean Fever: Is Fatty Liver Affected by Addition of Aerobic Exercise

Who Can Participate

Age: 30Years - 55Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Women diagnosed with Familial Mediterranean Fever
  • Obese women
  • Women who have non-alcoholic fatty liver disease
  • Age between 30 and 55 years
Not Eligible

You will not qualify if you...

  • People with heart disease
  • People with respiratory (lung) disease
  • People with kidney disease
  • People with cancer

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Outpatient Treatment

Duration - 6 months

Participants follow their daily colchicine medication and Mediterranean diet for six months. One group also performs elliptical aerobic exercise for 40 minutes three times weekly during this period.

Regular visits as needed for monitoring during the 6 months

Trial Site Locations

Total: 1 location

1

faculty of physical therapy Cairo university

Dokki, Giza Governorate, Egypt

Actively Recruiting

Loading map...

Research Team

A

Ali MA Ismail, lecturer

A

Ali Ismail, lecturer

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Constitution of a Biological Collection to Establish Preclin...

Chronic Liver Disease and Cirrhosis

Actively Recruiting

1 location

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Stud...

Non-alcoholic Fatty Liver Disease

Actively Recruiting

43 locations

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-A...

Non-alcoholic Fatty Liver Disease

Actively Recruiting

49 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here